Lumos Diagnostics Holdings Limited LDXHF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 98.36% | 98.36% | -74.04% | -74.04% | -100.96% |
| Total Depreciation and Amortization | 28.48% | 28.48% | -5.36% | -5.36% | -32.93% |
| Total Amortization of Deferred Charges | -0.47% | -0.47% | -- | -- | -37.25% |
| Total Other Non-Cash Items | -197.39% | -197.39% | 190.03% | 190.03% | 691.53% |
| Change in Net Operating Assets | 183.03% | 183.03% | -- | -- | -200.41% |
| Cash from Operations | 108.28% | 108.28% | 112.10% | 112.10% | -152.15% |
| Capital Expenditure | -6,433.33% | -6,433.33% | -994.12% | -994.12% | 16.28% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -6,433.33% | -6,433.33% | -994.12% | -994.12% | 55.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -139.76% | -139.76% | -17.58% | -17.58% | 12.41% |
| Issuance of Common Stock | -- | -- | -84.51% | -84.51% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 3,009.45% | 3,009.45% | -92.24% | -92.24% | 12.41% |
| Foreign Exchange rate Adjustments | -1,635.71% | -1,635.71% | 102.76% | 102.76% | 48.15% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 447.73% | 447.73% | 209.61% | 209.61% | -170.12% |